Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015
The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
Objective To identify severe hypoglycemia events, defined as emergency department visits or hospitalizations for hypoglycemia, in patients with type 2 diabetes receiving care in a large health system and to identify patient characteristics associated with severe hypoglycemia events. Research design and methods This was a retrospective cohort study from January 2006 to December 2015 using the electronic medical record in the Cleveland Clinic Health System (CCHS). Participants included 50,439 patients with type 2 diabetes receiving care in the CCHS. Number of severe hypoglycemia events and associated patient characteristics were identified. Results The incidence proportion of severe hypoglycemia increased from 0.12% in 2006 to 0.31% in 2015 ( P = 0.01). Compared with patients who did not experience severe hypoglycemia, those with severe hypoglycemia had similar median glycosylated hemoglobin (HbA 1c ) levels. More patients with severe hypoglycemia versus those without had a prior diagnosis of nonsevere hypoglycemia (9% vs. 2%, P P 1c P Conclusions In this retrospective study of patients with type 2 diabetes with severe hypoglycemia, patient characteristics were identified. Patients with severe hypoglycemia had previous nonsevere hypoglycemia diagnoses more frequently than those without. Identifying patients at high risk at the point of care can allow for change in modifiable risk factors and prevention of severe hypoglycemia events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“SH ED visits 3 (38) 2 (29) 2 (29) 4 (12) 3 (7) 4 (9) 7 (10) 5 (6) 4 (4) 12 (12)”
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389 · cited 1×
“While documented or probable symptomatic hypoglycemia or asymptomatic hypoglycemia (16) may occur more commonly than severe hypoglycemia, the occurrence of severe hypoglycemia remains an important problem.”
BackgroundHypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128 · cited 1×
“Identification of Severe Hypoglycemia Severe hypoglycemia events were identified based upon previous definitions (22,23).”
MethodBonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
The barrier of hypoglycemia in diabetes
Cryer, P. E. (2008) · Diabetes · doi:10.2337/db08-1084 · Cited by 725
International Hypoglycaemia Study Group (2017) · Diabetes Care · doi:10.2337/dc16-2215 · Cited by 608
Increased mortality of patients with diabetes reporting severe hypoglycemia
McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A. (2012) · Diabetes Care · doi:10.2337/dc11-2054 · Cited by 539
Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
Shorr, R. I. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360095010 · Cited by 459
Lipska, K. J., Ross, J. S., Wang, Y., Inzucchi, S. E., Minges, K., Karter, A. J., Huang, E. S., Desai, M. M., Gill, T. M., & Krumholz, H. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1824 · Cited by 391
The International Hypoglycaemia Study Group (2017) · Diabetologia · doi:10.1007/s00125-016-4146-6 · Cited by 360
The DCCT Research Group (1986) · Diabetes · doi:10.2337/diab.35.5.530 · Cited by 331
Kho, A. N., Hayes, M. G., Rasmussen-Torvik, L., Pacheco, J. A., Thompson, W. K., Armstrong, L. L., Denny, J. C., Peissig, P. L., Miller, A. W., Wei, W.-Q., et al. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000439 · Cited by 299
The impact of non-severe hypoglycemic events on work productivity and diabetes management
Brod, M., Christensen, T., Thomsen, T. L., & Bushnell, D. M. (2011) · Value in Health · doi:10.1016/j.jval.2011.02.001 · Cited by 284
Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits
Ginde, A. A., Blanc, P. G., Lieberman, R. M., & Camargo, C. A. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-4 · Cited by 234
Exhaustion Of Food Budgets At Month’s End And Hospital Admissions For Hypoglycemia
Seligman, H. K., Bolger, A. F., Guzman, D., López, A., & Bibbins-Domingo, K. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.0096 · Cited by 199
Assessing Potential Glycemic Overtreatment in Persons at Hypoglycemic Risk
Tseng, C.-L., Soroka, O., Maney, M., Aron, D. C., & Pogach, L. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12963 · Cited by 161
Intensive treatment and severe hypoglycemia among adults with type 2 diabetes
McCoy, R. G., Lipska, K. J., Yao, X., Ross, J. S., Montori, V. M., & Shah, N. D. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2275 · Cited by 143 · cited 2×
“Intensive treatmentofdiabetes in clinically complex patients has also been associated with increased risk of severe hypoglycemia (29).”
BackgroundFeil, D. G., Rajan, M., Soroka, O., Tseng, C., Miller, D. R., & Pogach, L. M. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03726.x · Cited by 142
Pathak, R. D., Schroeder, E. B., Seaquist, E. R., Zeng, C., Lafata, J. E., Thomas, A., Desai, J., Waitzfelder, B., Nichols, G. A., Lawrence, J. M., et al. (2016) · Diabetes Care · doi:10.2337/dc15-0858 · Cited by 140
Pantalone, K. M., Hobbs, T. M., Wells, B. J., Kong, S. X., Kattan, M. W., Bouchard, J., Yu, C., Sakurada, B., Milinovich, A., Weng, W., et al. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000093 · Cited by 134
Self-citationSignorovitch, J. E., Macaulay, D., Diener, M., Yan, Y., Wu, E. Q., Gruenberger, J. ‐., & Frier, B. M. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12031 · Cited by 125 · cited 1×
“Additional notable risks include decreased rating of health-related qualityof life (13) anddecreasedwork productivity (14) as well as accidents resulting in hospital visits (15).”
BackgroundThe incidence and costs of hypoglycemia in type 2 diabetes.
Quilliam, B. J., Simeone, J. C., Ozbay, A. B., & Kogut, S. J. (2011) · PubMed · Cited by 107
Alvarez-Guisasola, F., Yin, D. D., Nocea, G., Qiu, Y., & Mavros, P. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-86 · Cited by 78
Nunes, A. P., Yang, J., Radican, L., Engel, S. S., Kurtyka, K., Tunceli, K., Yu, S., Iglay, K., Doherty, M. C., & Dore, D. D. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.09.012 · Cited by 54
Deintensification of Routine Medical Services: The Next Frontier for Improving Care Quality
Kerr, E. A., & Hofer, T. P. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2292 · Cited by 19
Aron, D. C., Lowery, J. C., Tseng, C., Conlin, P. R., & Kahwati, L. C. (2014) · Implementation Science · doi:10.1186/1748-5908-9-58 · Cited by 14
Hypoglycemia During Therapy of Diabetes -- Endotext
DeGroot, L. J., Chrousos, G. P., Dungan, K. M., Kr, F., Grossman, A. B., Hershman, J. M., Koch, C. G., Korbonits, M., McLachlan, R., New, M. I., et al. (2000) · Cited by 1
Cited by
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 486
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Silbert, R., Salcido-Montenegro, A., Rodriguez-Gutierrez, R., Katabi, A., & McCoy, R. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1018-0 · Cited by 229
“[5, 77 , 78, 83] Importantly, while sulfonylurea and insulin medications do carry the highest risk of hypoglycemia, they can be used safely and should not be avoided if clinically necessary.”
Influential6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
McCoy, R. G., Lipska, K. J., Van Houten, H. K., & Shah, N. D. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.19099 · Cited by 141
Metadata
- Authors
- Misra-Hebert, A. D., Pantalone, K. M., Ji, X., Milinovich, A., Dey, T., Chagin, K. M., Bauman, J. M., Kattan, M. W., & Zimmerman, R. S.
- Affiliations
- Department of Internal Medicine and Center for Value-Based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, OH
- Cleveland Clinic (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-03-16
- Volume
- 41
- Issue
- 6
- Pages
- 1164-1171
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2792557235
- Cited by
- 46
- References
- 37
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 10 · 2019: 8 · 2018: 2
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (K08HS024128)
- Merck Investigators Studies Program (MERCK1702AMH)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- severe hypoglycemia, type 2 diabetes, risk factors, insulin, sulfonylureas, HbA1c, metformin, DPP-4 inhibitors, GLP-1 receptor agonists, comorbidities, race, body mass index, hypoglycemia prevention
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Hospitalization, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Retrospective Studies, Risk Factors, Severity of Illness Index, Sulfonylurea Compounds, Incidence, Delivery of Health Care, Integrated, Dipeptidyl-Peptidase IV Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.